Important Information About the CRE Infection Litigation from the Medical Device Legal Experts at Panish Shea & Boyle LLP

Nearly 200 patients at Ronald Reagan UCLA Medical Center, more than 70 patients at Cedars-Sinai Medical Center in Los Angeles and other patients at hospitals throughout the United States have been potentially exposed to a very serious infection called carbapenem-resistant enterobacteriaceae, or CRE.

The hospitals believe that these patients were exposed to the CRE infection during a procedure called “ERCP,” or endoscopic retrograde cholangiopancreatography.  In the case of UCLA, the hospital believes it has tracked all potential cases of the infection to two instruments used to perform ERCP, the Olympus TJFQ 180V Endoscope.  We are currently investigating the exposures at other facilities.

UCLA has now contacted many of the exposed patients to inform them of the steps they should take regarding medical diagnosis and treatment and it is expected that Cedars-Sinai Medical Center and the other hospitals involved have or will do the same.  If you have been contacted by a hospital or physician, you should follow their recommendations.  If you have questions or concerns about treatment you have received, you should contact the hospital directly.

All patients exposed to these contaminated instruments have legal rights against the responsible parties.

Panish Shea & Boyle is currently representing a number of patients who underwent ERCP procedures at UCLA and at other hospitals who later developed the CRE infection.  As of this date, we have filed two lawsuits involving serious injuries as a result of this exposure, including the death of one patient.  The claims that have been filed are against the manufacturer of the suspected endoscope, the Olympus America Medical company.  We have not sued the hospital involved.  Our investigation revealed that the manufacturer redesigned the endoscope in 2014, but failed to develop an effective method to clean the instrument.  We believe that this failure has now caused hundreds of patients to be exposed to the highly drug-resistant CRE infection.

If you believe that you, or a loved one, were exposed to the CRE infection as a result of a procedure, you should act quickly to protect the rights you have against the responsible parties. Panish Shea & Boyle stands ready to assist with these very important legal issues. The firm specializes in medical device cases like this. Please contact us with any questions or concerns you have about your legal rights, or about the best way to proceed with bringing a claim. We handle cases of this type strictly on a contingency fee basis, so we can conduct a thorough investigation without any risk to you.

Please email attorneys Kevin Boyle (boyle@psblaw.com) or Pete Kaufman (kaufman@psblaw.com) for an immediate response or call them toll free at 877-800-1700 or 310-435-3541 (cell phone).

Click here to learn more about Panish Shea & Boyle.

Articles and Media about the CRE outbreak featuring attorneys Kevin Boyle and Pete Kaufman:

Click here for February 26, 2015 Los Angeles Time Article
Click here for February 25, 2015 Los Angeles Time Article
Click here for February 20, 2015 CNN Article
Click here for February 19, 2015 New York Times Article
Click here for February 18, 2015 ABC News Article
Other Resources

February 19, 2015 FDA Safety Notice Regarding Design of ERCP Duodenoscopes